Trending News

#Clinical trial #Covid-19 #Moderna

Positive data from Moderna study of Covid-19 vaccine in children 

Moderna has announced positive interim data from its Phase II/III study (KidCOVE) of mRNA-1273, the company’s vaccine candidate against Covid-19, in children six to 12 years of age.   This interim analysis showed a robust neutralising antibody response after two doses of mRNA-1273 at the 50µg dose level with a favourable… Read More

#News #Trending News

#Collaboration #Drug discovery

This week in drug discovery (25-29 October)  

News round-up by DDW’s Megan Thomas for 25-29 October   DDW’s Megan Thomas has selected five stories which highlight the results that can be achieved through collaboration in the drug discovery sector.    1. Australian researchers identify new pathways to target breast cancer  A… Read More

#News #Trending News

#Biologics / Biotechnology #Cancer immunotherapy #Drug discovery #Flow Cytometry #Immuno-oncology #Webinar

Webinar offers insight into pharmacological reactions

Dr Nina Senutovitch, Senior Scientist, Sartorius, notes that more efficient and powerful tools are critical for furthering the development of highly target-specific immunotherapies, such as adoptive cell transfer therapies. These include Chimeric Antigen Receptor T cells (CAR-T), that harness an individual’s own immune system to attack cancerous cells. … Read More

#News #Trending News

#Comment #Drug discovery #ELRIG #Events

ELRIG UK comments on Drug Discovery 2021 

The Fall Issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & ELRIG UK supplement ahead of ELRIG UK’s Drug Discovery 2021 in Liverpool, October 19-20, 2021. In it, ELRIG UK’s General Manager Sanj Kumar welcomes the event and introduces the themes.   In 2019, ELRIG’s flagship scientific… Read More

#Exclusive Content #News #Opinion #Trending News

#Cancer research #Hormone therapy #Institute of Cancer Research

‘Gut bugs’ can drive prostate cancer growth and treatment resistance 

Scientists revealed in a new study how gut bacteria contribute to the progression of advanced prostate cancers and their resistance to hormone therapy by providing an alternative source of growth-promoting androgens, or male hormones.  Hormone therapy is the standard of care for advanced prostate cancer and works… Read More

#Cancer Research #News #Trending News

#Immunology / Virology & Vaccines #Malaria

WHO recommends GSK malaria vaccine for children at risk 

The World Health Organization (WHO) has recommended GlaxoSmithKline (GSK)’s RTS,S malaria vaccine to be given to children living in sub-Saharan Africa who are at risk of contracting Malaria.  RTS,S is the first and only malaria vaccine to have been shown in pivotal long-term clinical trials to significantly reduce… Read More

#News #Trending News

#Alzheimer's #Cancer research #Covid-19

This week in drug discovery (4-8 October) 

News round-up by DDW’s Megan Thomas for 4-8 October  For this week’s drug discovery round up, DDW’s Megan Thomas focuses on stories that provide answers to previously unanswered questions, or news that enables researchers and scientists to find those answers quickly.  1. Novel therapy could… Read More

#News #Trending News

#Alzheimer's #Clinical trials #Drug candidates #Drug discovery

First patients dosed in Phase I study for Alzheimer’s

AlzeCure Pharma has dosed the first patient in the company’s next clinical Phase I study (multiple ascending dose, MAD) with the candidate drug ACD856, focused on Alzheimer’s disease. ”It is satisfying that the clinical development program is proceeding according to plan and that we have now begun this follow-up Phase… Read More

#News #Trending News

#Antivirals #Covid-19 #Drug discovery

Covid-19 antiviral pill cuts hospitalisation and deaths in half

If authorised, molnupiravir could be the first oral antiviral medicine for Covid-19. Merck (known as MSD outside the United States and Canada) and Ridgeback Biotherapeutics have announced that molnupiravir, an investigational oral antiviral medicine, significantly reduced the risk of hospitalisation or death at a planned interim analysis of the Phase… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Blood cancer #Cancer research #Collaboration #Oncology

New cancer ‘inhibitor’ could lead to improved treatment options

Researchers have discovered a potential advancement in the treatment of chronic myeloid leukaemia (CML), which they hope will one day offer an improved option for treating patients with this form of blood cancer. The study– published in Science Translational Medicine and led by the University of Glasgow in collaboration with… Read More

#Cancer Research #Editor's Choice #News #Trending News

#Cancer #Cancer research #Research

This week in drug discovery (20-24 September) 

News round-up by DDW’s Megan Thomas for 20-24 September  September is Cancer Awareness Month, so this week DDW’s Megan Thomas has rounded up her top five news stories which showcase the work and research of scientists in the fight against cancer.   AstraZeneca Imfinzi combination effective… Read More

#News #Trending News

#Cancer research #Clinical trials #Institute of Cancer Research #Tumour biology

Promise in treatment-resistant advanced ovarian cancer 

A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial, shrinking tumours in half of patients. The combination of drugs, which both work by blocking signals cancer cells need to grow, could offer a new treatment option for women with… Read More

#Cancer Research #News #Trending News

#Cancer #Cancer research #Collaboration #Innovation

Cancer Research UK and University of Edinburgh start-up boost 

A University of Edinburgh business-support programme has partnered with Cancer Research UK to help build startup companies focused on tackling cancer.  The charity will fund up to ten participants in the second round of the university’s Data-Driven Entrepreneurship (DDE) Venture Builder Incubator, which supports postgraduate students, postdoctoral researchers and academic staff… Read More

#Cancer Research #News #Start-up Zone #Trending News